Hepatotoxicity Induced by Biological Agents: Clinical Features and Current Controversies

Abstract

Novel biological agents including cytokines and recombinant fusion proteins are increasingly prescribed for cancer, rheumatologic, autoimmune, and inflammatory diseases, and are currently being evaluated in hepatocellular carcinoma (HCC). They are classified by their mechanism of action and include tumor necrosis factor-alpha (TNF-α) antagonists, T cell mediated antitumor inhibitors, interleukin receptor antagonists, and immune checkpoint inhibitors (ICIs). Some ICIs cause frequent hepatotoxicity with a variable clinical, biochemical, and serological presentation, especially in patients receiving another immunomodulatory agent. Half of the cases of liver damage induced by biological agents spontaneously regress after drug withdrawal, but the others require steroid therapy. Unfortunately, there are no widely accepted recommendation for the use of corticosteroids in these patients, even though international cancer societies have their own guidelines. Differentiating drug-induced autoimmune hepatitis (DIAIH) from classic AIH is challenging for pathologists, but liver biopsy is valuable, particularly in cases with unclear clinical presentation. Interesting, novel histological patterns have been described in liver damage induced by these agents (i.e., endothelitis, ring granuloma and secundary sclerosing cholangitis associated with lymphocytic infiltration of cytotoxic CD8+T cells). Here, we describe the clinical and biochemical characteristics of patients with hepatotoxicity induced by TNF-α antagonists and ICIs. Controversial issues involved in the administration of corticosteroid therapy, and hepatitis B virus (HBV) reactivation induced by immunosuppressive therapy are also discussed.

Reversing the Inflammatory Process—25 Years of Tumor Necrosis Factor-α Inhibitors

“…Further, rare cases of drug-induced hepatotoxicity have been reported for infliximab monotherapy used for the treatment of IBD. However, the reported serologic and pathologic characteristics of this liver injury mostly resolve following the discontinuation of infliximab [84].…”

Global Lake Health in the Anthropocene: Societal Implications and Treatment Strategies

“…Algal blooms might directly threaten human health as certain cyanobacterial strains produce toxins, causing respiratory, gastrointestinal, and dermatological issues (Funari & Testai, 2008). A wide range of symptoms can be triggered by cyanotoxins, with hepatotoxicity (Hernandez & Bessone, 2022) and neurotoxicity (Hinojosa et al., 2019) effects leading to cellular and genomic damage, protein synthesis inhibition and potential carcinogenesis in humans and wildlife (Funari & Testai, 2008). Cyanobacterial blooms have been related to the death of a large variety of organisms (Benayache et al., 2022; Carmichael & Boyer, 2016; Chen et al., 2009; Codd et al., 2015; Lugomela et al., 2006; Trevino‐Garrison et al., 2015).…”

Overview of the immunological mechanisms in hepatitis B virus reactivation: Implications for disease progression and management strategies

“…The early onset of acute liver failure is attributed to the destructive effects of HBV reactivation-induced immunological responses, which are accompanied by the substantial release of inflammatory mediators. This situation can result in hepatic encephalopathy, coagulopathy, and multi-organ failure[ 96 ].…”